CD4 and neoplasm: The immunophenotype of tumor cells overlaps with that of other types of ALCL with strong CD30 expression, positivity for cytotoxic markers, frequent CD4 expression, and negativity or focal positivity for T-cell-associated antigens CD3, CD5, and CD7.